Startseite Clinical significance of pleural effusion mesothelin in malignant pleural mesothelioma
Artikel
Lizenziert
Nicht lizenziert Erfordert eine Authentifizierung

Clinical significance of pleural effusion mesothelin in malignant pleural mesothelioma

  • Shusai Yamada , Chiharu Tabata EMAIL logo , Rie Tabata , Kazuya Fukuoka und Takashi Nakano
Veröffentlicht/Copyright: 22. Juni 2011
Veröffentlichen auch Sie bei De Gruyter Brill

Abstract

Background: Malignant pleural mesothelioma (MPM) is an aggressive malignant tumor of mesothelial origin associated with asbestos exposure. MPM has a limited response to conventional chemotherapy and radiotherapy, so early diagnosis of MPM is very important. This study investigated the pleural effusion mesothelin levels in patients with MPM and compared them to those of a population with a non-malignant pleuritis or lung cancer involving malignant pleural effusion.

Methods: The pleural effusion mesothelin concentrations were measured in 45 MPM patients and 53 non-MPM individuals (24 individuals with non-malignant pleural effusions and 29 individuals with lung cancer involving malignant pleural effusion).

Results: This study demonstrated that patients with MPM had significantly higher pleural effusion mesothelin levels than a population with non-malignant pleuritis or lung cancer involving malignant pleural effusion. The difference in overall survival between the groups with pleural effusion mesothelin levels lower and higher than the assumed cut-off of 10 nM was significant.

Conclusions: The data suggest that the pleural effusion mesothelin concentration could be useful as an aid for the diagnosis of MPM.


Corresponding author: Chiharu Tabata, MD, PhD, Division of Respiratory Medicine, Department of Internal Medicine, Hyogo College of Medicine, 1-1 Mukogawa-cho, Nishinomiya, Hyogo 663-8501, Japan Phone: +81-798-45-6596, Fax: +81-798-45-6597

Received: 2010-12-17
Accepted: 2011-5-20
Published Online: 2011-06-22
Published in Print: 2011-10-01

©2011 by Walter de Gruyter Berlin Boston

Artikel in diesem Heft

  1. Editorial
  2. Laboratory medicine: an essential partner in the care of cancer patients
  3. Reviews
  4. Circulating tumor cells as emerging tumor biomarkers in breast cancer
  5. Prognostic, therapeutic and diagnostic potential of microRNAs in non-small cell lung cancer
  6. Increased plasma concentrations of tumour markers in the absence of neoplasia
  7. Recent progress and clinical importance on pharmacogenetics in cancer therapy
  8. Genetics and Molecular Diagnostics
  9. Genotyping of the hemochromatosis HFE p.H63D and p.C282Y mutations by high-resolution melting with the Rotor-Gene 6000® instrument
  10. General Clinical Chemistry and Laboratory Medicine
  11. Mapping point-of-care performance using locally-smoothed median and maximum absolute difference curves
  12. The use of inflammatory markers as a method for discharging patients post hip or knee arthroplasty
  13. Significant elevation of plasma pentraxin 3 in patients with pelvic inflammatory disease
  14. Combined effects of coffee consumption and serum γ-glutamyltransferase on serum C-reactive protein in middle-aged and elderly Japanese men and women
  15. Multicentre comparison of free thyroid hormones immunoassays: the Immunocheck study
  16. Comparative evaluation of capillary zone electrophoresis and HPLC in the determination of carbohydrate-deficient transferrin
  17. Determinants of blood levels of some thrombogenic biomarkers in healthy Arab adolescent subjects
  18. Analytical performance of a multiplexed, bead-based cytokine detection system in small volume samples
  19. Diagnostic utility of a soluble cytokeratin 18 assay for gastrointestinal graft-vs.-host disease detection
  20. Cancer Diagnostics
  21. The correlation between zinc and insulin-like growth factor 1 (IGF-1), its binding protein (IGFBP-3) and prostate-specific antigen (PSA) in prostate cancer
  22. Differential expression of CDC25 phosphatases splice variants in human breast cancer cells
  23. Serum APRIL, a potential tumor marker in pancreatic cancer
  24. Clinical significance of pleural effusion mesothelin in malignant pleural mesothelioma
  25. Infectious Diseases
  26. New serum biomarkers for detection of tuberculosis using surface-enhanced laser desorption/ionization time-of-flight mass spectrometry
  27. Cardiovascular Diseases
  28. Association of a functional polymorphism in the MMP7 gene promoter with susceptibility to vulnerable carotid plaque in a Han Chinese Population
  29. Diabetes
  30. Glycated albumin may be a possible alternative to hemoglobin A1c in diabetic patients with anemia
  31. A simple micro-photometric method for urinary iodine determination
  32. Letters to the Editor
  33. Clinically needed sensitivity for very low levels of Factor XIII: not yet proven for a new functional assay
  34. Apolipoprotein A5-12238 T>C gene polymorphism and risk factors for metabolic syndrome in the Guo Shan Yao and the Han populations
  35. Congress Abstracts
  36. 10.1515/CCLM.2011.738
  37. 1st National Congress of Laboratory Medicine
Heruntergeladen am 8.9.2025 von https://www.degruyterbrill.com/document/doi/10.1515/CCLM.2011.242/pdf
Button zum nach oben scrollen